Purespring to develop gene therapies for the kidney
Interviewee/Contributor
Richard Francis
Organisation
Purespring Therapeutics Ltd
Strategy
Forbion to create and grow biotech companies
Interviewee/Contributor
Sander Slootweg and Juliette Audet
Organisation
Forbion
Real world evidence is changing regulatory policy
Interviewee/Contributor
Marie Manley and Zina Chatzidimitriadou
Organisation
Sidley Austin LLP
New treatments for amyotrophic lateral sclerosis
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
Using wastewater surveillance to control Covid-19
Interviewee/Contributor
Gerard Brandon
Organisation
DeepVerge Plc
Transatlantic partnerships in life science
Interviewee/Contributor
Olivier Litzka
Organisation
Andera Partners
The role of oncolytic viruses in immuno-oncology
Interviewee/Contributor
Bernard Huber and Paul Higham
Organisation
Oryx GmbH & Co KG and Valo Therapeutics Ltd
Establishing a new role for real world evidence
Interviewee/Contributor
Tara Raveendran
Organisation
Shore Capital Ltd
The role of base and prime editing in therapeutics
Interviewee/Contributor
Jonathan Frampton
Organisation
Horizon Discovery Group Plc
The race to develop a COVID-19 vaccine
Interviewee/Contributor
Peter Charlish
Organisation
MedNous